BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31969795)

  • 1. A Review of the Scientific Rigor, Reproducibility, and Transparency Studies Conducted by the ABRF Research Groups.
    Mische SM; Fisher NC; Meyn SM; Sol-Church K; Hegstad-Davies RL; Weis-Garcia F; Adams M; Ashton JM; Delventhal KM; Dragon JA; Holmes L; Jagtap P; Kubow KE; Mason CE; Palmblad M; Searle BC; Turck CW; Knudtson KL
    J Biomol Tech; 2020 Apr; 31(1):11-26. PubMed ID: 31969795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on Scientific Shared Resource Rigor and Reproducibility.
    Knudtson KL; Carnahan RH; Hegstad-Davies RL; Fisher NC; Hicks B; Lopez PA; Meyn SM; Mische SM; Weis-Garcia F; White LD; Sol-Church K
    J Biomol Tech; 2019 Sep; 30(3):36-44. PubMed ID: 31452645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting Up Mass Cytometry in a Shared Resource Lab Environment.
    Warth S; Kunkel D
    Methods Mol Biol; 2019; 1989():3-11. PubMed ID: 31077095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing for the Unprecedented: The Association of Biomolecular Resource Facilities (ABRF) Community Coronavirus Disease 2019 (COVID-19) Pandemic Response Part 1: Efforts to Sustainably Ramp Down Core Facility Activities.
    Kigenyi J; Mische SM; Porter DM; Rappoport JZ; Vinard A
    J Biomol Tech; 2020 Dec; 31(4):119-124. PubMed ID: 32999636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Core Survey Highlights the Challenges Facing Data Analysis Facilities.
    Dragon JA; Gates C; Sui SH; Hutchinson JN; Karuturi RKM; Kucukural A; Polson S; Riva A; Settles ML; Thimmapuram J; Levine SS
    J Biomol Tech; 2020 Jul; 31(2):66-73. PubMed ID: 32382253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rigor, Reproducibility, and Transparency in Shared Research Resources: Follow-Up Survey and Recommendations for Improvements.
    Ott AW; Sol-Church K; Deshpande GM; Knudtson KL; Meyn SM; Mische SM; Taatjes DJ; Sturges MR; Gregory CW
    J Biomol Tech; 2022 Oct; 33(3):. PubMed ID: 36910580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2012/2013 ABRF Proteomic Research Group Study: Assessing Longitudinal Intralaboratory Variability in Routine Peptide Liquid Chromatography Tandem Mass Spectrometry Analyses.
    Bennett KL; Wang X; Bystrom CE; Chambers MC; Andacht TM; Dangott LJ; Elortza F; Leszyk J; Molina H; Moritz RL; Phinney BS; Thompson JW; Bunger MK; Tabb DL
    Mol Cell Proteomics; 2015 Dec; 14(12):3299-309. PubMed ID: 26435129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metrics for Success: Strategies for Enabling Core Facility Performance and Assessing Outcomes.
    Turpen PB; Hockberger PE; Meyn SM; Nicklin C; Tabarini D; Auger JA
    J Biomol Tech; 2016 Apr; 27(1):25-39. PubMed ID: 26848284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ABRF MARG microarray survey 2005: taking the pulse of the microarray field.
    Knudtson KL; Auer H; Brooks AI; Griffin C; Grills G; Hester S; Khitrov G; Lilley KS; Massimi A; Tiesman JP; Viale A
    J Biomol Tech; 2006 Apr; 17(2):176-86. PubMed ID: 16741246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlaboratory studies and initiatives developing standards for proteomics.
    Ivanov AR; Colangelo CM; Dufresne CP; Friedman DB; Lilley KS; Mechtler K; Phinney BS; Rose KL; Rudnick PA; Searle BC; Shaffer SA; Weintraub ST
    Proteomics; 2013 Mar; 13(6):904-9. PubMed ID: 23319436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Journey to Now: The Origins of ABRF.
    Niece RL
    J Biomol Tech; 2019 Sep; 30(3):32-35. PubMed ID: 31452646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABRF-PRG07: advanced quantitative proteomics study.
    Falick AM; Lane WS; Lilley KS; MacCoss MJ; Phinney BS; Sherman NE; Weintraub ST; Witkowska HE; Yates NA
    J Biomol Tech; 2011 Apr; 22(1):21-6. PubMed ID: 21455478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix.
    Cheema AK; Asara JM; Wang Y; Neubert TA; Tolstikov V; Turck CW
    J Biomol Tech; 2015 Sep; 26(3):83-9. PubMed ID: 26290656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the trustworthiness, usefulness, and ethics of biomedical research through an innovative and comprehensive institutional initiative.
    Strech D; Weissgerber T; Dirnagl U;
    PLoS Biol; 2020 Feb; 18(2):e3000576. PubMed ID: 32045410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of biomolecular resource facilities survey: service laboratory funding.
    Ogorzalek Loo R; Nicolet CM; Niece RL; Young M; Simpson JT
    J Biomol Tech; 2009 Jul; 20(3):180-5. PubMed ID: 19568457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations to enhance rigor and reproducibility in biomedical research.
    Brito JJ; Li J; Moore JH; Greene CS; Nogoy NA; Garmire LX; Mangul S
    Gigascience; 2020 Jun; 9(6):. PubMed ID: 32479592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for proteomics core facilities.
    Lilley KS; Deery MJ; Gatto L
    Proteomics; 2011 Mar; 11(6):1017-25. PubMed ID: 21360676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABRF Proteomics Research Group studies: educational exercises for qualitative and quantitative proteomic analyses.
    Friedman DB; Andacht TM; Bunger MK; Chien AS; Hawke DH; Krijgsveld J; Lane WS; Lilley KS; MacCoss MJ; Moritz RL; Settlage RE; Sherman NE; Weintraub ST; Witkowska HE; Yates NA; Turck CW
    Proteomics; 2011 Apr; 11(8):1371-81. PubMed ID: 21394914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.